The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms

This publication has 8 references indexed in Scilit:

• Generic entry, price competition, and market segmentation in the prescription drug market
  International Journal of Industrial Organization, 2008
• Prescription Drug Spending Trends In The United States: Looking Beyond The Turning Point
  Health Affairs, 2008
• The outsourcing of R&D through acquisitions in the pharmaceutical industry
  Published by Elsevier ,2005
• The Value of Certainty in Intellectual Property Rights: Stock Market Reactions to Patent Litigation.
  SSRN Electronic Journal, 2005
• A Simple Model of Pharmaceutical Price Dynamics
  The Journal of Law and Economics, 2003
• The price of innovation: new estimates of drug development costs
  Journal of Health Economics, 2003
• Returns on Research and Development for 1990s New Drug Introductions
  PharmacoEconomics, 2002
• A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity
  Econometrica, 1980